カテゴリー： QYResearch, 世界

世界の肝性脳症薬市場 2019年

【英語タイトル】Global Hepatic Encephalopathy Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08954）・商品コード：DATA909X08954
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、肝性脳症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、RBX-2660、KLS-13019、GR-3027、SYNB-1020、その他に、用途別には、クリニック、病院、その他にセグメント区分し、肝性脳症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・肝性脳症薬の世界市場概要
・肝性脳症薬の製造コスト構成分析
・肝性脳症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・肝性脳症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・肝性脳症薬のセグメント分析（種類別）
（RBX-2660、KLS-13019、GR-3027、SYNB-1020、その他）
・肝性脳症薬のセグメント分析（用途別）
（クリニック、病院、その他）
・肝性脳症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Alfa Wassermann S.p.A、Cosmo Pharmaceuticals S.p.A、Horizon Pharma Plc、KannaLife Sciences, Inc.、Ocera Therapeutics, Inc.、Rebiotix Inc.、Spherium Biomed S.L.、Umecrine Cognition AB、）
・肝性脳症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Hepatic Encephalopathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hepatic Encephalopathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatic Encephalopathy Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hepatic Encephalopathy Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hepatic Encephalopathy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alfa Wassermann S.p.A
Cosmo Pharmaceuticals S.p.A
Horizon Pharma Plc
KannaLife Sciences, Inc.
Ocera Therapeutics, Inc.
Rebiotix Inc.
Spherium Biomed S.L.
Umecrine Cognition AB

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
RBX-2660
KLS-13019
GR-3027
SYNB-1020
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hepatic Encephalopathy Drug
1.1 Definition of Hepatic Encephalopathy Drug
1.2 Hepatic Encephalopathy Drug Segment by Type
1.2.1 Global Hepatic Encephalopathy Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 RBX-2660
1.2.3 KLS-13019
1.2.4 GR-3027
1.2.5 SYNB-1020
1.2.6 Others
1.3 Hepatic Encephalopathy Drug Segment by Applications
1.3.1 Global Hepatic Encephalopathy Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Hepatic Encephalopathy Drug Overall Market
1.4.1 Global Hepatic Encephalopathy Drug Revenue (2014-2025)
1.4.2 Global Hepatic Encephalopathy Drug Production (2014-2025)
1.4.3 North America Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.4 Europe Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.5 China Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.6 Japan Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hepatic Encephalopathy Drug Status and Prospect (2014-2025)
1.4.8 India Hepatic Encephalopathy Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drug
2.3 Manufacturing Process Analysis of Hepatic Encephalopathy Drug
2.4 Industry Chain Structure of Hepatic Encephalopathy Drug

3 Development and Manufacturing Plants Analysis of Hepatic Encephalopathy Drug
3.1 Capacity and Commercial Production Date
3.2 Global Hepatic Encephalopathy Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hepatic Encephalopathy Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hepatic Encephalopathy Drug Production and Capacity Analysis
4.2 Hepatic Encephalopathy Drug Revenue Analysis
4.3 Hepatic Encephalopathy Drug Price Analysis
4.4 Market Concentration Degree

5 Hepatic Encephalopathy Drug Regional Market Analysis
5.1 Hepatic Encephalopathy Drug Production by Regions
5.1.1 Global Hepatic Encephalopathy Drug Production by Regions
5.1.2 Global Hepatic Encephalopathy Drug Revenue by Regions
5.2 Hepatic Encephalopathy Drug Consumption by Regions
5.3 North America Hepatic Encephalopathy Drug Market Analysis
5.3.1 North America Hepatic Encephalopathy Drug Production
5.3.2 North America Hepatic Encephalopathy Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hepatic Encephalopathy Drug Import and Export
5.4 Europe Hepatic Encephalopathy Drug Market Analysis
5.4.1 Europe Hepatic Encephalopathy Drug Production
5.4.2 Europe Hepatic Encephalopathy Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hepatic Encephalopathy Drug Import and Export
5.5 China Hepatic Encephalopathy Drug Market Analysis
5.5.1 China Hepatic Encephalopathy Drug Production
5.5.2 China Hepatic Encephalopathy Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hepatic Encephalopathy Drug Import and Export
5.6 Japan Hepatic Encephalopathy Drug Market Analysis
5.6.1 Japan Hepatic Encephalopathy Drug Production
5.6.2 Japan Hepatic Encephalopathy Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hepatic Encephalopathy Drug Import and Export
5.7 Southeast Asia Hepatic Encephalopathy Drug Market Analysis
5.7.1 Southeast Asia Hepatic Encephalopathy Drug Production
5.7.2 Southeast Asia Hepatic Encephalopathy Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hepatic Encephalopathy Drug Import and Export
5.8 India Hepatic Encephalopathy Drug Market Analysis
5.8.1 India Hepatic Encephalopathy Drug Production
5.8.2 India Hepatic Encephalopathy Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hepatic Encephalopathy Drug Import and Export

6 Hepatic Encephalopathy Drug Segment Market Analysis (by Type)
6.1 Global Hepatic Encephalopathy Drug Production by Type
6.2 Global Hepatic Encephalopathy Drug Revenue by Type
6.3 Hepatic Encephalopathy Drug Price by Type

7 Hepatic Encephalopathy Drug Segment Market Analysis (by Application)
7.1 Global Hepatic Encephalopathy Drug Consumption by Application
7.2 Global Hepatic Encephalopathy Drug Consumption Market Share by Application (2014-2019)

8 Hepatic Encephalopathy Drug Major Manufacturers Analysis
8.1 Alfa Wassermann S.p.A
8.1.1 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
8.1.2 Alfa Wassermann S.p.A Product Introduction, Application and Specification
8.1.3 Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cosmo Pharmaceuticals S.p.A
8.2.1 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
8.2.2 Cosmo Pharmaceuticals S.p.A Product Introduction, Application and Specification
8.2.3 Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Horizon Pharma Plc
8.3.1 Horizon Pharma Plc Hepatic Encephalopathy Drug Production Sites and Area Served
8.3.2 Horizon Pharma Plc Product Introduction, Application and Specification
8.3.3 Horizon Pharma Plc Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 KannaLife Sciences, Inc.
8.4.1 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.4.2 KannaLife Sciences, Inc. Product Introduction, Application and Specification
8.4.3 KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Ocera Therapeutics, Inc.
8.5.1 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.5.2 Ocera Therapeutics, Inc. Product Introduction, Application and Specification
8.5.3 Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Rebiotix Inc.
8.6.1 Rebiotix Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
8.6.2 Rebiotix Inc. Product Introduction, Application and Specification
8.6.3 Rebiotix Inc. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Spherium Biomed S.L.
8.7.1 Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Sites and Area Served
8.7.2 Spherium Biomed S.L. Product Introduction, Application and Specification
8.7.3 Spherium Biomed S.L. Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Umecrine Cognition AB
8.8.1 Umecrine Cognition AB Hepatic Encephalopathy Drug Production Sites and Area Served
8.8.2 Umecrine Cognition AB Product Introduction, Application and Specification
8.8.3 Umecrine Cognition AB Hepatic Encephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Hepatic Encephalopathy Drug Market
9.1 Global Hepatic Encephalopathy Drug Market Trend Analysis
9.1.1 Global Hepatic Encephalopathy Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Hepatic Encephalopathy Drug Regional Market Trend
9.2.1 North America Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.2 Europe Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.3 China Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.4 Japan Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.5 Southeast Asia Hepatic Encephalopathy Drug Forecast 2019-2025
9.2.6 India Hepatic Encephalopathy Drug Forecast 2019-2025
9.3 Hepatic Encephalopathy Drug Market Trend (Product Type)
9.4 Hepatic Encephalopathy Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hepatic Encephalopathy Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hepatic Encephalopathy Drug
Table Global Hepatic Encephalopathy Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hepatic Encephalopathy Drug Production Market Share by Types in 2018
Figure RBX-2660 Product Picture
Figure KLS-13019 Product Picture
Figure GR-3027 Product Picture
Figure SYNB-1020 Product Picture
Figure Others Product Picture
Table Global Hepatic Encephalopathy Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hepatic Encephalopathy Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) (2014-2025)
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) (2014-2025)
Figure North America Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Europe Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure China Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Japan Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Figure India Hepatic Encephalopathy Drug Market Size (Million USD) (2014-2025)
Table Hepatic Encephalopathy Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hepatic Encephalopathy Drug in 2018
Figure Manufacturing Process Analysis of Hepatic Encephalopathy Drug
Figure Industry Chain Structure of Hepatic Encephalopathy Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hepatic Encephalopathy Drug Manufacturing Plants Distribution
Table Hepatic Encephalopathy Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hepatic Encephalopathy Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Hepatic Encephalopathy Drug Production Share by Manufacturers in 2018
Table Hepatic Encephalopathy Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hepatic Encephalopathy Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hepatic Encephalopathy Drug Revenue Share by Manufacturers in 2018
Table Hepatic Encephalopathy Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hepatic Encephalopathy Drug Production by Regions 2014-2019 (K Pcs)
Table Global Hepatic Encephalopathy Drug Production Market Share by Regions 2014-2019
Figure Global Hepatic Encephalopathy Drug Production Market Share by Regions in 2018
Table Global Hepatic Encephalopathy Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Hepatic Encephalopathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Hepatic Encephalopathy Drug Revenue Market Share by Regions in 2018
Table Global Hepatic Encephalopathy Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Hepatic Encephalopathy Drug Consumption Market Share by Regions 2014-2019
Figure North America Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure China Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure India Hepatic Encephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Hepatic Encephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Hepatic Encephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hepatic Encephalopathy Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hepatic Encephalopathy Drug Market Share by Application (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Alfa Wassermann S.p.A Hepatic Encephalopathy Drug Main Business and Markets Served
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Sites and Area Served
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Cosmo Pharmaceuticals S.p.A Hepatic Encephalopathy Drug Main Business and Markets Served
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Sites and Area Served
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Horizon Pharma Plc Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Horizon Pharma Plc Hepatic Encephalopathy Drug Main Business and Markets Served
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table KannaLife Sciences, Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Ocera Therapeutics, Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Rebiotix Inc. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Rebiotix Inc. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Rebiotix Inc. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Sites and Area Served
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Spherium Biomed S.L. Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Spherium Biomed S.L. Hepatic Encephalopathy Drug Main Business and Markets Served
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Sites and Area Served
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Product Introduction, Application and Specification
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Growth Rate (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Production Market Share (2014-2019)
Figure Umecrine Cognition AB Hepatic Encephalopathy Drug Revenue Market Share (2014-2019)
Table Umecrine Cognition AB Hepatic Encephalopathy Drug Main Business and Markets Served
Figure Global Hepatic Encephalopathy Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hepatic Encephalopathy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hepatic Encephalopathy Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hepatic Encephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hepatic Encephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hepatic Encephalopathy Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Hepatic Encephalopathy Drug by Application (2019-2025)
Table Hepatic Encephalopathy Drug Distributors List
Table Hepatic Encephalopathy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Alfa Wassermann S.p.A、Cosmo Pharmaceuticals S.p.A、Horizon Pharma Plc、KannaLife Sciences, Inc.、Ocera Therapeutics, Inc.、Rebiotix Inc.、Spherium Biomed S.L.、Umecrine Cognition AB、

★調査レポート[世界の肝性脳症薬市場 2019年] (コード：DATA909X08954)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肝性脳症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の退形成性乏突起膠腫薬市場 2019年
    DATA909X03539 / QYResearch / 2019年11月15日 / ※本調査レポートは、退形成性乏突起膠腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他に、用途別には、病院、クリニック、研究センターにセグメント区分し、退形成性乏突起膠腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・退形成性乏突起膠腫薬の世界市場概要 ・退形成性乏突起膠腫薬の製造コスト構成分析 ・退形成性乏突起膠腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・退形成性乏突起膠腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・退形成性乏突起膠腫薬のセグメント分析（種類別） （CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他）...The global Anaplastic Oligoastrocytoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anaplastic Oligoastrocytoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Oligoastrocytoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anaplastic Oligoastrocytoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆